Penumbra Aktie

242,00 EUR -2,60 EUR -1,06 %

22:13:23

BMN

280,01 USD -3,46 USD -1,22 %

21:59:54

BTT

Penumbra jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.9,45 Mrd. EUR

KGV665,58Div. Rendite0,00%

WKNA14Y65

ISINUS70975L1070

SymbolPEN

Penumbra Aktien News

Sortieren:Datum Meistgelesen

19.11.25PR NewswirePenumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference

05.11.25PR NewswirePenumbra, Inc. Reports Third Quarter 2025 Financial Results

03.11.25PR NewswireLatest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism

WerbungPenumbra-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

27.10.25PR NewswireLandmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism

08.10.25PR NewswirePenumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025

09.09.25PR NewswireNew Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile

27.08.25PR NewswirePenumbra, Inc. Names Shruthi Narayan as Company President

20.08.25PR NewswirePenumbra, Inc. to Present at Upcoming Investor Conferences

30.07.25PR NewswirePenumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference

29.07.25PR NewswirePenumbra, Inc. Reports Second Quarter 2025 Financial Results

01.07.25PR NewswirePenumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025

16.06.25PR NewswirePenumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial

05.06.25PR NewswirePenumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization

20.05.25PR NewswirePenumbra, Inc. to Present at Upcoming Investor Conferences

29.04.25PR NewswirePenumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

23.04.25PR NewswirePenumbra, Inc. Reports First Quarter 2025 Financial Results

08.04.25PR NewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Penumbra, Inc. (NYSE: PEN)

03.04.25PR NewswirePenumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025

02.04.25PR NewswireSeven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits

21.02.25PR NewswirePenumbra, Inc. Announces Don Kassing will Retire from Board of Directors

21.01.25PR NewswirePenumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025

30.12.24PR NewswirePenumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

20.11.24PR NewswirePenumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

05.11.24PR NewswireNew Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compa...

30.10.24PR NewswirePenumbra, Inc. Reports Third Quarter 2024 Financial Results

14.10.24PR NewswirePenumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke

02.10.24PR NewswirePenumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024

16.09.24PR NewswirePenumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe

27.08.24PR NewswirePenumbra, Inc. to Present at the Baird Global Healthcare Conference

21.08.24PR NewswirePenumbra, Inc. to Present at the Wells Fargo Healthcare Conference

13.08.24PR NewswirePenumbra, Inc. Announces $200 Million Share Repurchase Authorization

02.08.24PR NewswirePenumbra, Inc. to Present at the Canaccord Genuity Growth Conference

30.07.24PR NewswirePenumbra, Inc. Reports Second Quarter 2024 Financial Results

02.07.24PR NewswirePenumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

04.06.24PR NewswirePenumbra, Inc. to Present at the Truist Securities MedTech Conference

23.05.24PR NewswirePenumbra, Inc. to Present at the William Blair Growth Stock Conference

07.05.24PR NewswirePenumbra, Inc. Reports First Quarter 2024 Financial Results

01.05.24PR NewswirePenumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference

23.04.24PR NewswirePenumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

09.04.24PR NewswirePenumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Penumbra News

Penumbra News: auf dieser Seite finden Sie alle Penumbra News und Nachrichten zur Penumbra Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Penumbra News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Penumbra News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.